Furthermore, the percent reduction of the PASI correlated with serum levels of IL-6, but not IL-17 or IL-22, before photo(chemo)therapy [27], indicating that psoriasis patients with high serum IL-6 levels might be more susceptible to the effects of photo(chemo)therapy. This evidence concerns the gene IL6 and psoriasis.